US 11,864,578 B2
Oral product
Feng Gao, Midlothian, VA (US); Frank Scott Atchley, Tarpon Springs, FL (US); Gregory Griscik, Midlothian, VA (US); Christopher Joseph Dinovi, Ruther Glen, VA (US); and Phillip M. Hulan, Midlothian, VA (US)
Assigned to Altria Client Services LLC, Richmond, VA (US)
Filed by Altria Client Services LLC, Richmond, VA (US)
Filed on Mar. 24, 2021, as Appl. No. 17/211,128.
Application 17/211,128 is a continuation of application No. 16/592,978, filed on Oct. 4, 2019, granted, now 10,959,454, issued on Mar. 30, 2021.
Application 16/592,978 is a continuation of application No. 15/943,096, filed on Apr. 2, 2018, granted, now 10,631,568, issued on Apr. 28, 2020.
Application 15/943,096 is a continuation of application No. 13/744,973, filed on Jan. 18, 2013, granted, now 9,930,909, issued on Apr. 3, 2018.
Claims priority of provisional application 61/588,890, filed on Jan. 20, 2012.
Prior Publication US 2021/0204586 A1, Jul. 8, 2021
Int. Cl. A24B 13/00 (2006.01); A24B 15/16 (2020.01)
CPC A24B 13/00 (2013.01) [A24B 15/16 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An oral product comprising:
a fiber-polymer matrix defining pockets, the fiber-polymer matrix including,
a mouth-soluble polymer matrix including,
a mouth-soluble polymer, and
a non-tobacco cellulosic material in the mouth-soluble polymer matrix;
nicotine or a nicotine derivative in the pockets of the mouth-soluble polymer matrix;
a flavorant in the pockets of the mouth-soluble polymer matrix; and
a medium-chain triglyceride in the mouth-soluble polymer matrix, wherein the oral product has a compressibility at 250 N ranging from 60% to 98%.